Mammalian sterile 20-like kinase-3b (Mst3b, encoded by Stk24), regulates axon outgrowth in embryonic cortical neurons in culture, but its role in vivo and in neural repair is unknown. Here we show that Mst3b mediates the axon-promoting effects of trophic factors in mature rat retinal ganglion cells (RGCs) and dorsal root ganglion (DRG) neurons, and is essential for axon regeneration in vivo. Reducing Mst3b levels using short hairpin RNA prevented RGCs and DRG neurons from regenerating axons in response to growth factors in culture, as did expression of a kinase-dead Mst3b mutant. Conversely, expression of constitutively active Mst3b enabled both types of neurons to extend axons without growth factors. In vivo, RGCs lacking Mst3b failed to regenerate injured axons when stimulated by intraocular inflammation. DRG neurons regenerating axons in vivo showed elevated Mst3b activity, and reducing Mst3b expression attenuated regeneration and p42/44 MAPK activation. Thus, Mst3b regulates axon regeneration in both CNS and PNS neurons.
a r t I C l e S Axon regeneration occurs readily after injury in the mature PNS (peripheral nervous system) but not within the CNS. The optic nerve is a classic model of a CNS pathway that does not regenerate when injured. Mature retinal ganglion cells (RGCs) show an abortive sprouting reaction following nerve injury but no long-distance axon growth 1 . Unexpectedly, however, significant regeneration can be achieved by inducing an inflammatory response in the eye. Implanting a peripheral nerve fragment into the vitreous 2 , injuring the lens [3] [4] [5] , or injecting zymosan 6, 7 or ciliary neurotrophic factor 8 into the eye all lead to an influx of macrophages and enable RGCs to extend lengthy axons beyond the site of nerve injury. Macrophages release a growth factor, oncomodulin, that stimulates optic nerve regeneration in vivo provided cyclic AMP levels are elevated 9, 10 . In the PNS, sensory neurons of the dorsal root ganglia (DRG) regenerate their peripherally directed axons readily after injury. The signals that initiate this process remain uncertain, but may include disruption of retrograde signaling, calcium influx, exposure of the proximal stump to an inflammatory environment 11, 12 or generation of novel retrogradely transported signals at the injury site 13 .
Several lines of evidence suggest that axon outgrowth involves a purine-sensitive protein kinase. The purine analog 6-thioguanine blocks the neurite-promoting effects of trophic agents [14] [15] [16] and inhibits the activity of a 45-50 kDa protein kinase 17 . Inosine, a naturally occurring purine nucleoside, reverses the inhibitory effects of 6-thioguanine and can promote axon outgrowth in several types of neurons on its own 15, 16, 18 . On the basis of these observations, we isolated Mst3b as a purine-sensitive protein kinase and showed that it mediates the axon-promoting effects of inosine and neurotrophic factors in cell culture 15, 16 . Mst3b is rapidly activated when embryonic cortical neurons or PC12 cells are exposed to neurotrophins, and inhibiting the expression or activity of Mst3b prevents these cells from extending axons in response to inosine or trophic factors 16 . In vivo, inosine stimulates the growth of axon collaterals from intact neurons if other brain pathways have been injured [19] [20] [21] . This observation suggests the possibility that Mst3b might play a role in axon growth in the mature nervous system.
In the present study, we have investigated whether Mst3b is required for axon growth in mature neurons. Our results show that Mst3b plays an essential role in the response of both RGCs and DRG neurons to neurotrophic factors through changes in its kinase activity. In addition, suppressing Mst3b expression attenuates axon regeneration in the mature optic nerve and radial nerve. These findings place Mst3b as a key regulator of axon regeneration in the CNS and PNS, and as a potential therapeutic target for improving outcome after axonal injury.
RESULTS
As a model for CNS regeneration, we examined the ability of retinal ganglion cells to extend axons past the site of injury in the mature rat optic nerve when stimulated by intraocular inflammation 3, 6 . For the PNS, we used the radial nerve, in which axon regeneration occurs readily after injury in the absence of exogenous stimulation 22 . In both cases, we investigated whether reducing Mst3b expression suppresses the ability of the relevant projection neurons to extend axons in cell culture, whether Mst3b regulates axon growth through changes in its kinase activity and whether altering Mst3b abundance suppresses axon regeneration in vivo.
Mst3b is essential for axon outgrowth in RGCs
We transfected RGCs with plasmids expressing a short hairpin RNA to Stk24 isoform a (subsequently referred to as Mst3b shRNA) a r t I C l e S to investigate whether these cells require Mst3b to regenerate axons in response to appropriate growth factors in culture ( Fig. 1) . We dissociated retinas from normal, intact rats, placed these cells into culture, and transfected them with plasmids expressing enhanced green fluorescent protein (EGFP) and either a control shRNA or an Mst3b-specific shRNA that was previously shown to knock down Mst3b expression 16 . The control shRNA differs from Mst3b shRNA in two nucleotide positions and does not affect axon outgrowth 16 . After 3 d of treatment with the combination of oncomodulin, mannose and forskolin, RGCs expressing the control shRNA showed triple the axon outgrowth of untreated RGCs (P < 0.001; Fig. 1a,b,h) . In contrast, RGCs expressing Mst3b shRNA showed little response to these factors ( Fig. 1,c,h) .
To investigate whether the reduced outgrowth seen in this study is specifically related to a reduction in Mst3b levels, we cotransfected cells with two plasmids, one expressing Mst3b shRNA and the other expressing His-tagged human Mst3b. The mRNA sequence of STK24 isoform a, encoding human Mst3b, differs considerably from that of the rat gene, and its expression is not blocked by the shRNA construct used here 16 . We verified the presence of exogenous human Mst3b by staining cells with an antibody (anti-His) that recognizes His-tagged Mst3b (Fig. 1e) . Cotransfecting RGCs with the two plasmids restored RGCs' ability to extend axons in response to growth factors (P < 0.01; Fig. 1d,e,h) . Thus, the effect of Mst3b shRNA in blocking outgrowth depended specifically on its ability to knock down Mst3b expression, and not on off-target effects.
Mst3b regulates growth through changes in kinase activity
To determine whether Mst3b exerts its effects through its kinase activity, we transfected RGCs with a plasmid expressing a mutant form of the protein with an amino acid change in the ATP-binding site 16 . Expression of this 'kinase-dead' Mst3b mutant eliminated the response of RGCs to growth factors ( Fig. 1f,h) .
To investigate whether the kinase activity of Mst3b plays a causative role in axon growth, we next transfected RGCs with a plasmid expressing a constitutively active mutant of Mst3b. To create constitutively active Mst3b, we mutated Thr190 to aspartate, a change that has been shown to activate Mst3, a splice variant of Mst3b 23 . Expression of constitutively active Mst3b enabled RGCs to grow axons even with growth factors absent ( Fig. 1g,h) . Thus, the kinase activity of Mst3b is necessary and sufficient for axon outgrowth in RGCs. Low-magnification photographs illustrating the transfection efficiency and outgrowth in these cultures are shown in Supplementary Figure 1 .
Mst3b depletion blocks optic nerve regeneration in vivo
To investigate the role of Mst3b in vivo, we injected adult rats intravitreally with adeno-associated virus-2 (AAV2) expressing EGFP from a cytomegalovirus promoter and, from a U6 promoter, either the shRNA that blocks Mst3b expression or the control shRNA. Rats survived for 4 weeks after viral infections before undergoing surgery to injure the optic nerve and induce intravitreal inflammation. The 4-week delay allowed high levels of shRNA expression and degradation of preexisting Mst3b. In conformity with earlier reports on the high infection were transfected with a plasmid expressing His-tagged human Mst3b (d,h). Expression of human Mst3b was verified by immunostaining for the His tag (e). Expression of kinase-dead (K/D) Mst3b blocked the effects of growth factors (f,h), whereas expression of constitutively active (C/A) Mst3b resulted in outgrowth even with growth factors absent (g,h). Scale bar, 40 µm. Each experiment included four blinded, independent observations (10-100 cells per well), and each experiment was repeated three times. *P < 0.05, **P < 0.01, ***P < 0.001, increase relative to untreated controls. † † † P < 0.001, decrease relative to control cells treated with growth factors. Error bars, s.e.m. (a-g) Representative photos of RGCs transfected with plasmids expressing the shRNA constructs and/or Mst3b variants shown on the left. Cells were exposed to media alone or to a combination of oncomodulin, mannose and forskolin (Ocm/m/f), as indicated. Cells were fixed 3 d later and immunostained for EGFP, a marker for transfected cells, and either βIII-tubulin, a marker for RGCs (antibody TuJ1), or the myc-His tag present on recombinant human Mst3b. (h) Quantitation of axon outgrowth. RGCs transfected with control shRNA extended axons when exposed to Ocm/m/f (a,b,h), whereas cells expressing Mst3b shRNA did not (c,h). Outgrowth was restored when RGCs expressing Mst3b shRNA a r t I C l e S efficiency of AAV2 (refs. [24] [25] [26] , we found that AAV2 expressing EGFP and either of the two shRNAs enabled us to visualize EGFP in up to 68% of RGCs 4 weeks after infection ( Fig. 2a ). Infecting RGCs with AAV2 expressing Mst3b shRNA strongly suppressed Mst3b expression.
Using an antibody that recognizes the N-terminal region of Mst3b 16 , we detected the protein in essentially every EGFP-positive RGC expressing control shRNA, but observed an ~85% reduction in average staining intensity in EGFP-positive RGCs expressing Mst3b shRNA (Fig. 2b,c) .
As expected from the known tropism of AAV2 and the 4-week separation between viral injections and macrophage induction, intraocular injections of AAV2 expressing EGFP and Mst3b shRNA did not infect macrophages nor block their activation ( Fig. 2d) .
To verify that virally mediated Mst3b reduction still suppressed axon growth after the time delay used in our in vivo studies, we waited Mst3b is essential for optic nerve regeneration. RGCs were infected with AAV2 expressing EGFP plus either control or Mst3b shRNA. The optic nerve was crushed 4 weeks later, and the lens was injured to induce inflammation and transform RGCs into an active growth state. Regeneration was quantified 2 weeks thereafter. (a) Longitudinal sections through the optic nerve stained for GAP-43 (red, a marker for regenerating axons) and EGFP (green, a marker for transfected neurons). Asterisk, site of nerve injury; box, region magnified in b. Scale bar, 100 µm. (b) Area distal to the injury site from a rat expressing Mst3b shRNA in 4 weeks after injecting AAVs, dissected and dissociated retinas, and cultured the cells 6 in the presence or absence of oncomodulin, mannose and forskolin 6, 10, 27 . In RGCs expressing the control shRNA, the addition of oncomodulin, forskolin and mannose caused a doubling in average axon length (P < 0.001; Supplementary Fig. 2 ). RGCs expressing Mst3b shRNA extended much shorter axons with or without growth factors present (difference from control-infected RGCs significant at P < 0.001; Supplementary Fig. 2) . Thus, the effect of Mst3b knockdown remained strong several weeks after viral infection and resulted in a reduction of both baseline and growth factor-stimulated axon outgrowth. The lower overall outgrowth seen in Figure 1h compared to that in Supplementary Figure 2 may reflect a general decrease in RGCs' ability to extend axons after being exposed to the reagents used for the transient transfections.
In vivo, regenerating axons that arise from infected RGCs were distinguished by virtue of staining positively for both EGFP and GAP-43. The membrane phosphoprotein GAP-43 is normally undetectable in the mature optic nerve, but is strongly induced in axons undergoing regeneration 2, 3, 28 . Profiles that are GAP-43 + EGFP − , by contrast, are expected to reflect regenerating axons that arise from uninfected neurons. Remnants of degenerating axons that already contained EGFP before injury, but that are not regenerating, would be GAP-43 − EGFP + . Rats infected with control shRNA (N = 7) showed many GAP-43 + EGFP + axons regenerating ≥0.5 mm past the lesion site ( Fig. 3a, top) . In contrast, rats with Mst3b knocked down (N = 7) showed 97% fewer GAP-43 + GFP + regenerating axons ( Fig. 3b ) (difference significant at P < 0.001; Fig. 3a bottom and 3c) . In all cases, we normalized the number of axons by the percentage of RGCs found to be EGFP-positive to account for individual variations in infection rates. As an internal control, we also quantified the number of regenerating axons arising from uninfected RGCs (GAP-43 + EGFP − ) and found this number to be similar between rats infected with AAV2 expressing control versus Mst3b shRNA ( Fig. 3c) . Thus, Mst3b suppression essentially eliminated axon regeneration in the mature optic nerve, but did not alter the growth capacity of neighboring uninfected neurons.
The effect of Mst3b knockdown on axon regeneration was not due to changes in cell survival. RGCs begin to undergo apoptotic cell death a few days after optic nerve injury, and by 2 weeks ~80% will have died 29, 30 . Lens injury enhances survival to allow 40%-50% of RGCs to remain alive after 2 weeks. To investigate whether the loss of axon regeneration after Mst3b knockdown in vivo might reflect a selective loss of the infected RGCs, we examined the survival of these cells after infection with AAV2 carrying either control or Mst3b shRNA. The number of surviving RGCs was the same in both cases (8.8 ± 0.3 TuJ1 + cells per 200 microns per section with Mst3b shRNA, and 7.3 ± 0.4 TuJ1 + cells per 200 microns per section with the control shRNA). We also calculated the percentage of RGCs that were EGFP positive with and without surgery. In rats expressing Mst3b shRNA, the percentage of RGCs that was EGFP-positive was 61.1 ± 3.3% in rats that survived 6 weeks and did not have surgery (N = 4) and 68.3 ± 1.9% after optic nerve crush plus lens injury (N = 7; difference not significant: t = 1.89, P ≈ 0.09). Rats infected with the control shRNA showed similar results, although the infection rates were lower. In these cases, 16.2 ± 2.2% of RGCs were EGFP positive in rats that did not have surgery (N = 4) compared to 12.1 ± 1.6% 2 weeks after optic nerve crush plus lens injury (N = 7; difference not significant: t = 1.51, P ≈ 0.16).
Mst3b knockdown blocks NGF-induced outgrowth in DRG neurons
In contrast to the optic nerve, axon regeneration occurs readily in peripheral nerves after injury. Axons that arise from neurons in cervical DRGs 7 and 8 begin to regenerate past a lesion site in the radial nerve within a day or two, with full recovery of function taking place over a few weeks 22, 31 . As with RGCs, we first used transient
Human Mst3b NGF (a-f) Representative photos of DRG neurons transfected with plasmids expressing shRNA constructs and/or variant forms of Mst3b, as labeled. Cells were exposed to NGF (50 ng ml −1 ) or media alone. Cells were fixed 3 d later and immunostained to detect EGFP, a marker for transfected cells, and βIII-tubulin to identify neurons (antibody TuJ1).
(g) Quantitation of axon growth. Cells expressing the control shRNA (a,b,g) extended neurites when treated with NGF (b,g). Cells expressing Mst3b shRNA (arrowheads; c,g) did not respond to NGF; an untransfected cell in the same field showed outgrowth (arrow). a r t I C l e S transfection assays to evaluate whether Mst3b mediates the response of adult DRG neurons to trophic factors, in this case nerve growth factor (NGF) (Fig. 4) . We dissociated DRG neurons from uninfected, unlesioned rats and transfected these with plasmids expressing EGFP and either control or Mst3b-specific shRNA. After being exposed to NGF for 3 d, DRG neurons expressing the control shRNA showed twice the average axon length of untreated controls (difference significant at P < 0.001: Fig. 4a,b,g) , whereas DRG neurons expressing Mst3b shRNA showed no response ( Fig. 4c,g) . To investigate whether this failure to respond to NGF was due specifically to reduced Mst3b expression, we cotransfected DRG neurons with plasmids expressing Mst3b shRNA and a cDNA encoding the homologous human protein MST3b/STK24, as above. Coexpression of the shRNA and the human cDNA restored DRG neurons' ability to respond to NGF (P < 0.01; Fig. 4d,g) . Thus, the effect of Mst3b shRNA in blocking outgrowth was due specifically to knockdown of Mst3b expression. These studies show that Mst3b is essential for DRG neurons' ability to extend axons in response to NGF. As in RGCs, we next investigated whether Mst3b regulates axon outgrowth through changes in its kinase activity. To do this, we transfected DRG neurons with either the kinase-dead or constitutively active form of Mst3b described above. Expression of kinase-dead Mst3b eliminated the ability of DRG neurons to extend axons in response to NGF (Fig. 4e,g) . In contrast, transfection with constitutively active Mst3b caused these cells to extend long axons even in the absence of NGF (Fig. 4f,g) . Thus, the axon-promoting effect of NGF on DRG neurons seems to be mediated by changes in the kinase activity of Mst3b.
Mst3b knockdown attenuates peripheral nerve regeneration
Four weeks after injecting AAV2 expressing EGFP and either control shRNA or Mst3b shRNA into cervical ganglia, the percentage of TuJ1 + neurons found to be transfected was 21.4 ± 2.9% and 34.9 ± 2.1%, respectively. Transduction was specific to neurons ( Fig. 5a ) and included small peptidergic (IB4 − ) and non-peptidergic (IB4 + ) neurons, as well as large neurons positive for the neurofilament protein NF200 (Fig. 5b,c) . Compared to cells expressing control shRNA, average Mst3b immunostaining was ~85% lower in DRG neurons transfected with AAV2 expressing Mst3b shRNA (Fig. 5d) .
As with RGCs, we examined whether virally mediated knockdown of Mst3b would affect DRG neurons' ability to regenerate axons when tested several weeks later. Four weeks after infecting cervical DRGs in vivo with AAV2 expressing either control or Mst3b-specific shRNA, we dissociated and cultured DRG neurons on poly-d-lysine-coated glass coverslips. In the absence of NGF, EGFP-positive DRG neurons showed similar outgrowth irrespective of which shRNA was being expressed. However, whereas neurons expressing the control shRNA on average tripled their axon length when exposed to NGF, neurons expressing Mst3b shRNA showed no detectable response (Supplementary Fig. 3 ; difference between groups significant at P < 0.02).
To investigate the role of Mst3b in peripheral nerve regeneration in vivo, we prepared a separate group of rats in which cervical DRG neurons were injected with AAV2 expressing EGFP and either the control or Mst3b-specific shRNA. We then crushed the radial nerve 4 weeks later and evaluated axon regeneration after 3 d, a time point at which injured axons have normally grown several millimeters beyond the injury site ( Fig. 6) . As in the optic nerve, we assessed regeneration arising from infected neurons as the number of axons beyond the injury site that were positive for both GAP-43 and EGFP, and then corrected this number by the percentage of cells that were transfected to account for individual variations in transfection efficiency. In DRGs injected with AAV2 expressing the control shRNA, many EGFP + GAP-43 + axons extended 1-2 mm distal to the injury site, and some extended as far as 5 mm (Fig. 6a,b,e,f; N = 8 ). Rats expressing Mst3b shRNA showed an 80%-85% reduction in axon growth a r t I C l e S (N = 9; difference from controls significant at P < 0.001 for 0.5 mm, P < 0.01 for 1 and 2 mm; not significant at 3, 4 and 5 mm: Fig. 6c,d,f) .
We also evaluated regeneration in uninfected DRG neurons in these same rats-that is, the number of axons that were GAP-43 + EGFP − , normalized by the percentage of cells that were uninfected. Axons arising from uninfected DRG neurons regenerated to a similar extent regardless of whether their neighbors expressed the control or Mst3b shRNA (Fig. 6g) . In sum, knocking down Mst3b expression in DRG neurons strongly attenuated, but did not eliminate, the regeneration of injured axons in vivo. The number of DRG neurons (TuJ1 + ) that survived infection with AAV carrying Mst3b shRNA (142.8 ± 6.0 per mm 2 ) was similar to that seen after infection with AAV carrying control shRNA (139.5 ± 8.8 per mm 2 ). Thus, knocking down Mst3b expression did not differentially impair DRG neuron survival.
Mst3b kinase activity changes during regeneration
To determine whether the activity of Mst3b in DRG neurons increases during regeneration, we isolated ganglia 3 d after peripheral nerve injury and compared their Mst3b kinase activity with that of control DRG neurons using immunoprecipitation-kinase (IP-kinase) assays as described 16 . We precipitated Mst3b from DRG lysates using the antibody to the N-terminal region of the protein and evaluated kinase activity using histone protein HF1 as an experimental substrate. DRG neurons undergoing axon regeneration showed 2.5-fold more Mst3b kinase activity than control neurons (P < 0.01). 6-Thioguanine, an inhibitor of Mst3b, attenuated this increase (P < 0.05: Fig. 7a,b) .
The MAP kinase pathway contributes to the development and regeneration of peripheral axons 32, 33 and to the effect of NGF in inducing outgrowth in PC12 cells 34, 35 . The observation that knocking down Mst3b inhibits outgrowth in both sensory neurons and PC12 cells 16 is consistent with the possibility that it acts through a MAPK pathway. To examine how Mst3b fits into the signal transduction cascade that leads to axon outgrowth, we compared p42/44 MAPK phosphorylation in neurons expressing control versus Mst3b shRNA. In sections through DRGs expressing Mst3b shRNA, we detected immunostaining for phospho-p42/44 MAPK in 11% of neurons, compared to 87% of neurons expressing the control shRNA ( Fig. 7c-e ). The total p42/44 MAPK immunostaining did not differ between the two groups.
DISCUSSION
Mst3b was recently shown to be a neuron-specific protein kinase that is essential for axon outgrowth in embryonic cortical neurons and PC12 cells in culture 16 . The present study demonstrates that Mst3b also mediates the effects of trophic factors in stimulating axon outgrowth in adult RGCs and DRG neurons, that it exerts these effects through changes in its kinase activity and that this kinase is essential for mature RGCs and DRG neurons to regenerate injured axons in vivo.
To study the role of Mst3b in the CNS, we used the adult rat optic nerve as an accessible and widely studied example of a CNS pathway in which some regeneration can be achieved by inducing an inflammatory reaction in the eye 3, 6 . A macrophage-derived growth factor, oncomodulin, can mimic the effect of intravitreal inflammation when introduced into the eye together with an agent to elevate intracellular cAMP; mannose, which is also required for the effects of oncomodulin, is normally abundant in the eye 6, 10, 27 . As shown here, depletion of Mst3b greatly reduced the ability of adult rat RGCs to extend axons in response to oncomodulin, mannose and forskolin in culture, and eliminated axon regeneration in vivo. The effect of Mst3b shRNA on axon outgrowth can be attributed specifically to the loss of Mst3b protein, as responsiveness to growth factors was rescued when RGCs expressing Mst3b shRNA were cotransfected with plasmids Mst3b is also important for axon regeneration in the peripheral nervous system. Depletion of Mst3b eliminated the ability of DRG neurons to respond to NGF in culture and attenuated axon regeneration after radial nerve crush in vivo. As with RGCs, the role of Mst3b in DRG neurons was shown to require its kinase activity. Expression of a kinase-dead mutant form of Mst3b blocked NGF-induced outgrowth in culture, and, notably, expression of a constitutively active Mst3b mutant enabled DRG neurons to extend axons even in the absence of growth factors.
In vivo, DRG neurons expressing Mst3b shRNA showed 80% less axon regeneration 3 d after nerve injury than neurons expressing the control shRNA or than untransfected neurons in the same ganglia. Nonetheless, the continued occurrence of some regeneration even when Mst3b abundance was reduced suggests either that there was enough Mst3b remaining to allow some regeneration or that axon regeneration in the PNS may use both Mst3b-dependent and Mst3b-independent mechanisms. DRG neurons extend processes in response to trophic factors and, through integrin signaling, in response to substrate molecules 36 . In culture, DRG neurons expressing Mst3b shRNA continued to show basal outgrowth when cultured on poly-d-lysine, but they were unable to respond to NGF. Peripheral nerves, but not optic nerves, are rich in laminin, and this may contribute to the ability of DRG neurons expressing Mst3b shRNA, but not similarly infected RGCs, to show some regeneration in vivo. The different amounts of regeneration in the two systems may also be due in part to the marked differences in inhibitory signals between the optic nerve and peripheral nerve 37, 38 .
Ste20, the prototypic member of the kinase family that includes Mst3b, functions as an upstream activator of a MAP kinase cascade that regulates budding in yeast. Ste20 relays the signal from a pheromone-sensitive, G protein-coupled receptor to Ste11; Ste11 in turn phosphorylates the MAPK kinase Ste7, which then phosphorylates Fus3, a MAPK 39, 40 . MAP kinase pathways are known to contribute to the development and regeneration of peripheral axons 32, 33 and to the effect of NGF in inducing outgrowth in PC12 cells 34, 35 . Thus, the observation that Mst3b depletion inhibits outgrowth in sensory neurons and PC12 cells 16 is consistent with the possibility that Mst3b activates a MAPK pathway in neurons. In conformity with this idea, we found that the kinase activity of Mst3b was elevated in DRG neurons undergoing axon regeneration in vivo, and that reduction of Mst3b expression diminished p42/44 MAPK phosphorylation in these neurons. Together, these data support the idea that Mst3b controls axon outgrowth through changes in its kinase activity and subsequent activation of a MAP kinase signaling cascade.
When stimulated to go into an active growth state in vivo, RGCs show marked changes in the expression of genes associated with axon growth and cell survival 41 , and these changes resemble those seen in DRG neurons undergoing axon regeneration in the PNS [42] [43] [44] . The results of the present study suggest that Mst3b could be part of a common signaling pathway that mediates the effects of trophic factors in controlling the expression of axon-outgrowth-related genes in CNS and PNS neurons.
In summary, we have shown that Mst3b, through its kinase activity, is a key regulator of axon regeneration in the adult optic nerve and radial nerve. It will be important to investigate whether Mst3b regulates axon regeneration in other parts of the CNS and PNS, and whether expression of a constitutively active form of Mst3b can augment the limited amount of growth that is at present achievable 
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Note: Supplementary information is available on the Nature Neuroscience website.
ONLINE METHODS
Intravitreal AAV virus injections and optic nerve surgery. All surgical procedures were approved by the Institutional Animal Care and Use Committee of Children's Hospital Boston. We anesthetized adult male Fischer rats (220-250 g) by intraperitoneal injections of ketamine (75 mg per kilogram body weight; Hospira) and medetomidine hydrochloride (Domitor) (0.5 mg kg −1 ; Pfizer) and injected ~10 9 AAV particles (2 × 10 5 infectious units) in 10 µl PBS into the vitreous through the lateral aspect of the eyeball using a glass capillary. Withdrawing fluid from the anterior chamber of the eye alleviated increases in intraocular pressure. We took care to avoid injury to the lens, as evidenced by fundoscopic examination. After allowing 4 weeks to achieve high transgene expression, we performed optic nerve surgery in approximately half of the rats as described 3 . We injured the lens at the time of the optic nerve crush by inserting the tip of a 25-gauge needle into the eye 2 mm anterior to the nerve head, perpendicular to the sclera, and puncturing the lens to a depth of about 2 mm. Lens injury initiates an inflammatory reaction in the eye and stimulates RGCs to enter an active growth state 3, 41 . Buprenorphine (0.1 mg kg −1 ; Reckitt Benckiser) was administered for 48 h after surgery. dRg injections and radial nerve crush. We anesthetized adult male Sprague-Dawley rats (250-300 g) by intraperitoneal injections of ketamine (75 mg kg −1 ) and medetomidine hydrochloride (0.5 mg kg −1 ), exposed the C7 and C8 DRGs through laminectomy, and injected ~10 8 AAV particles (2 × 10 4 infectious units) in 1 µl of PBS per DRG using a glass capillary. We then closed the muscle in layers, sutured the skin, and administered buprenorphine (0.1 mg kg −1 ) for 72 h. After allowing 4 weeks to achieve high levels of transgene expression, we crushed the radial nerve in approximately half of the rats. We made a 1-1.5 cm incision, exposed the radial nerve, and crushed it twice for 40 s each using fine forceps, then administered analgesic (buprenorphine, 0.1 mg kg −1 ) for 72 h after surgery.
Sciatic nerve crush and mst3b activity. We anesthetized adult male Sprague-Dawley rats (180-200 g) as above, exposed the sciatic nerve, and crushed it three times for 10 s each, 1 cm above the point where it bifurcates into the common peritoneal nerve and the tibial nerve. We verified the nerve injury by the clearing of the nerve at the lesion site, closed the muscles and skin using 2-0 silk sutures, and administered buprenorphine as above. After 3 d, we overdosed rats with isoflurane, traced the sciatic nerves back to the L4 and L5 dorsal root ganglia and excised these ganglia. We homogenized ganglia in RIPA buffer with sodium vanadate as a phosphatase inhibitor, then carried out immunoprecipitation with anti-Mst3b and performed kinase assays with or without 6-thioguanine inhibition as described 16 .
Preparation for histology. We killed rats under deep anesthesia 2 weeks after optic nerve crush plus lens injury or 3 d after radial nerve crush, by perfusion through the heart with saline plus heparin followed by 4% paraformaldehyde. In the case of the radial nerve studies, we conducted pilot experiments to establish an appropriate survival time at which to visualize a substantial front of regenerating axons distal to the injury site and clear differences between rats expressing the control versus mst3b shRNA. These criteria were met at 3 d, whereas at 7 d many axons had regenerated considerable distances past the injury site in both groups. We removed tissue (eyes, optic nerves, C7 and C8 DRG, radial nerves), postfixed in 4% paraformaldehyde (4 °C overnight), transferred to 15% and then 30% sucrose solution (in PBS, each overnight at 4 °C) and embedded samples in OCT medium (Miles). We then cut frozen sections (15 µm thick) longitudinally on a cryostat, thaw-mounted these onto glass slides (Superfrost plus; Fisher), and stored the slides at −20 °C until further use.
Immunohistochemistry on tissue sections. We carried out immunohistochemistry to visualize GAP-43-positive axons in optic nerve and radial nerve sections as described 3 . For this, we used the IgG fraction from an antiserum to GAP-43 prepared in sheep (1:2,500) 45 followed by an Alexa Fluor 594-conjugated secondary antibody to sheep IgG (1:1,000, Molecular Probes). Sections were double-labeled with an anti-GFP made in rabbit (1:2,000; Abcam) followed by an Alexa Fluor 488-conjugated secondary antibody to rabbit IgG (1:500, Molecular Probes).
To visualize transfected cells in the retina and DRG, we incubated rehydrated sections in blocking solution (PBS containing 0.3% Triton X-100, PBST) and 4% goat serum (60 min, 20 °C), and double-labeled these with a rabbit anti-GFP (1:2,000; Abcam) and mouse anti-βIII tubulin (1:500, TuJ1, Babco) overnight at 4 °C in a PBS solution containing 4% goat serum. βIII-tubulin is a selective marker for RGCs in the ganglion cell layer 6, 46 and is also expressed in DRG neurons 47 . In some cases, we double-labeled sections with a rabbit anti-Mst3b 16 (1:10 for eye sections, 1:500 for DRG sections) and mouse anti-GFP (1:100 for eye sections, 1:200 for DRG sections; Molecular Probes) to examine whether Mst3b expression was suppressed in transfected cells.
In other cases, we double-labeled cells with a mouse ED1 antibody to CD68 (1:200, Serotec) and rabbit anti-GFP (1:2,000, Abcam). In some cases, we stained DRG sections with fluorescent isolectin IB4 (Sigma) or mouse anti-NF200 (1:100; Serotec).
On the second day, we washed slides three times, 10 min each, in PBST and applied secondary antibodies (Alexa Fluor 488-conjugated goat anti-rabbit or anti-mouse IgG, 1:500, and Alexa Fluor 594-conjugated goat anti-rabbit or anti-mouse IgG, 1:500, Molecular Probes) for 1 h at 4 °C in a PBS solution containing 4% goat serum. Following two 10-min washes in PBST and a 10-min wash in PBS, slides were mounted in Fluorsave (Calbiochem). To study intracellular signaling pathways, we double-labeled DRG sections with anti-p42/44 MAPK or anti-phospho-p44/42 MAPK (made in rabbit; 1:100, Cell Signaling) and mouse anti-EGFP (1:200; Molecular Probes). Secondary antibodies included Alexa Fluor 594-conjugated goat anti-rabbit IgG (1:200) and Alexa Fluor 488-conjugated goat anti-mouse IgG (1:500, both Molecular Probes).
Quantitation of axon regeneration and cell survival.
We quantified GAP-43 + EGFP + axon growth in the optic nerve and radial nerve using published methods 3 , with 7-9 rats per condition. An observer blinded to sample identity quantified axon growth by counting the total number of GAP-43-positive and EGFP-positive axons arising from transfected RGCs or DRG neurons at specified distances past the lesion site (500 µm for the optic nerve; 500, 1,000, 2,000, 3,000, 4,000 and 5,000 µm for the radial nerve) in 4-6 longitudinal sections per nerve. The cross-sectional width of the nerve was measured at the point at which the counts were taken, and was used to calculate the number of axons per mm of nerve width. We then averaged the number of axons per millimeter over the sections and corrected this value to the transfection efficiency of the Mst3b shRNA infections (68% in the optic nerve and 35% in the radial nerve). Σa d , the total number of axons extending distance d in a nerve having a radius r, was estimated by summing over all sections, having a thickness t of 15 µm): To evaluate cell survival and infection efficiency, we counted both the total number of βIII-tubulin + RGCs and the number that were positive for both EGFP and βIII tubulin in 4-6 sections through the center of the retina of each rat, as previously described 6 . Similar methods were used to evaluate cell survival in DRGs. Results are expressed as mean ± s.e.m. of 7-9 rats per condition for each of the experimental groups. The significance of intergroup differences was evaluated by Student's t-test.
Rgc cultures. We dissociated and cultured retinas from adult Fischer rats that had received virus injection 4 weeks earlier ( Fig. 1) or from naive ( Supplementary  Fig. 2) adult Fisher rats (220-250 g) as described 6 . For transient transfection experiments, we transfected neurons from naive adult Fisher rats 24 h after plating with plasmids expressing EGFP and (i) an shRNA against Mst3b or (ii) a control shRNA, identical to the sequences used in the present in vivo experiments and in our previous study 16 . In some cases, we cotransfected RGCs with plasmids expressing Mst3b shRNA and wild-type myc-His-tagged human MST3b/ STK24, which differs significantly in its nucleotide sequence from rat Mst3b RNA and is unaffected by the shRNA 16 . In some cases, RGCs were transfected with plasmids expressing a mutant human Mst3b in which Lys65, which lies in the
